Securities code: Ningbo Menovo Pharmaceutical Co.Ltd(603538) securities abbreviation: Ningbo Menovo Pharmaceutical Co.Ltd(603538) Announcement No.: 2022032 convertible bond Code: 113618 convertible bond abbreviation: Meinuo convertible bond
Ningbo Menovo Pharmaceutical Co.Ltd(603538)
Announcement of convertible bond conversion results and share changes
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
Share conversion: as of March 31, 2022, a total of 42386000 yuan of “Meinuo convertible bonds” had been converted into shares of the company, with 1138209 shares, accounting for 0.761% of the total issued shares of the company before the convertible bonds began to be converted.
Convertible bonds not converted into shares: as of March 31, 2022, the amount of convertible bonds not converted into shares was RMB 477614000, accounting for 91.849% of the total issuance of convertible bonds.
1、 Overview of convertible bond issuance and listing
(I) approved by the reply on approving Ningbo Menovo Pharmaceutical Co.Ltd(603538) public issuance of convertible corporate bonds (zjxk [2020] No. 2377) of China Securities Regulatory Commission, Ningbo Menovo Pharmaceutical Co.Ltd(603538) (hereinafter referred to as “the company”) publicly issued 520 million yuan of convertible corporate bonds, with a total of 5.2 million pieces, a face value of 100 yuan each and a term of 6 years.
(II) with the consent of self regulatory decision [2021] No. 47 of Shanghai Stock Exchange, the company’s 520 million yuan convertible corporate bonds will be listed and traded in Shanghai Stock Exchange from February 4, 2021. The bonds are referred to as “menuo convertible bonds” for short and the bond code is “113618”.
(III) according to relevant regulations and the prospectus for Ningbo Menovo Pharmaceutical Co.Ltd(603538) public offering of convertible corporate bonds (hereinafter referred to as the “prospectus”), the “Mino convertible bonds” issued by the company can be converted into shares of the company from July 20, 2021, and the conversion price is 37.47 yuan / share. (IV) on December 30, 2021, the company’s 2021 stock option and restricted stock incentive plan
The grant registration was completed in Shanghai Branch of China Securities Depository and Clearing Co., Ltd., and the actual grant registration
1727860 restricted shares. According to the provisions of the prospectus, the conversion price is adjusted to 37.23
Yuan / share.
2、 Current share conversion of convertible bonds
From January 1, 2022 to March 31, 2022, the amount of “Meinuo convertible bonds” converted into shares is
42272000 yuan, with 1135189 shares formed due to the conversion of shares, accounting for the proportion of the company before the conversion of convertible bonds into shares
0.759% of the total issued shares. As of March 31, 2022, a total of 42386000 yuan has been accumulated
Yuan “Meinuo convertible bonds” have been converted into the company’s shares, with a cumulative number of 1138209 shares, accounting for the opening of convertible bonds
0.761% of the total issued shares of the company before the initial conversion, and the amount of convertible bonds that have not been converted is RMB
477614000 yuan, accounting for 91.849% of the total issuance of convertible bonds.
3、 Changes in share capital
Before the change, after the change of equity incentive restricted shares
Share category (cancellation of this convertible bond to share repurchase on December 31, 2021 (completed on January 24, 2022 (March 31, 2022))
Tradable shares with limited sales conditions 17411600 – 13 Cec Environmental Protection Co.Ltd(300172) 7860
Non tradable shares 14957557011351890150710759
Total share capital 1513167301135189 – 13 Xiongan Kerong Environment Technology Co.Ltd(300152) 438619
4、 Other
1. Contact Department: Office of the board of directors
2. Tel: 057487916065
3. Fax: 057487293786
It is hereby announced.
Ningbo Menovo Pharmaceutical Co.Ltd(603538)
Board of directors
April 2, 2022
